The Victorian Cancer Biobank (VCB) is a crucial part of the medical research landscape supporting researchers throughout Australia and around the world with the aim of delivering better clinical ...

The global bio-banks market, forecast to reach $216.3 million by 2018, faces challenges due to lack of standardized and quality biospecimens, the availability of which is crucial to clinical research ...

AXT and Krishagni Solutions are proud to announce their recent distributorship agreement for the OpenSpecimen biobanking software solution developed specifically for clinical researchers. OpenSpecimen ...

University Medical Center Utrecht central biobank will use OpenSpecimen to manage 3 million biospecimens for 300+ studies, which will likely be extended soon. The project's success displays the high ...